The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 25, 2020
Filed:
Apr. 12, 2018
Applicant:
Velicept Therapeutics, Inc., Malvern, PA (US);
Inventors:
Eliot Ohlstein, Glenmoore, PA (US);
Raymond E. Stevens, Jr., West Chester, PA (US);
H. Jeffrey Wilkins, Sellersville, PA (US);
Assignee:
Velicept Therapeutics, Inc., Wayne, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/196 (2006.01); A61K 9/20 (2006.01); A61K 9/50 (2006.01); A61K 9/16 (2006.01); A61K 9/24 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61P 31/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/196 (2013.01); A61K 9/0053 (2013.01); A61K 9/1676 (2013.01); A61K 9/209 (2013.01); A61K 9/2077 (2013.01); A61K 9/2081 (2013.01); A61K 9/5078 (2013.01); A61K 9/5084 (2013.01); A61K 45/06 (2013.01); A61P 31/10 (2018.01);
Abstract
This application relates to pharmaceutical compositions, comprising solabegron that are useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to methods for treating lower urinary tract symptoms utilizing the pharmaceutical compositions, comprising solabegron. In some embodiments, the pharmaceutical compositions, comprising solabegron comprise a dual release drug delivery system.